The Conversation (0)
LiveMint reported that Shares in Sun Pharmaceutical Industries Ltd (NSE:SUNPHARMA) fell as much as 2.4% on Monday on media reports the company is in talks to buy Sweden’s Meda AB for between $5 billion and $6 billion.
LiveMint reported that Shares in Sun Pharmaceutical Industries Ltd (NSE:SUNPHARMA) fell as much as 2.4% on Monday on media reports the company is in talks to buy Sweden’s Meda AB for between $5 billion and $6 billion.
As quoted in the market news:
Sun is in talks with a clutch of banks to raise funds for a possible deal, sources with direct knowledge told Reuters on Friday, declining to be identified. They did not say how far the discussions had advanced, or how likely it was that a deal would be reached.
Click here for the full report by Live Mint